The scholarship will recognize the core tenets of Monarch in awardees’ nucleic acid purification research
IPSWICH, Mass., March 17, 2025 /PRNewswire/ — Alongside the recent release of its updated Monarch® nucleic acid purification kits, New England Biolabs (NEB®) today announced a new Monarch Nucleic Acid Purification Scholarship recognizing individuals who use nucleic acid purification in their research that exemplifies the core tenets of Monarch – performance, sustainability and value.
“With this scholarship, we aim to recognize scientists of all experience levels who are using nucleic acid purification in their work to deliver research excellence, contribute to environmental stewardship, and support their communities,” says James Deng, Senior Product Marketing Manager for NEB’s nucleic acid purification portfolio. “We encourage anyone conducting impactful research involving nucleic acid purification to apply for this scholarship, and to learn more about the benefits of NEB’s Monarch kits.”
There will be three U.S. awardees, each receiving a scholarship of $2,025 to support their endeavors. Additionally, awardees and their work will be widely recognized and celebrated in NEB communications. The scholarship is open to U.S. residents aged 18 and older, and applications will be accepted through May 1, 2025.
NEB’s updated Monarch nucleic acid purification kits feature an optimized column design and utilize streamlined manufacturing and packaging processes. Together, these changes help ensure that the kits provide unmatched performance and improved sustainability, all of which translates into additional value for customers. Updated kits utilize up to 30% less plastic by weight in columns and collection tubes, as well as reduced plastic in reagent bottles, as compared to the leading supplier. Comprehensive column updates also include:
To learn more about the scholarship details, visit www.neb.com/MonarchScholarship.
To learn more about NEB’s Monarch DNA and RNA nucleic acid purification kits, visit www.nebmonarch.com.
About New England Biolabs
For over 50 years, New England Biolabs (NEB) has pioneered the discovery and production of innovative products tailored for molecular biology research. Our commitment to scientific discovery is evident in all that we do, including our ever-expanding product portfolio, investment in our basic and applied research program, and support of customers’ research in academia and industry, including cutting-edge technologies for use in molecular diagnostics and nucleic-acid vaccines development. Guided by our founding principles, NEB proactively invests in efforts to improve the well-being of our employees, surrounding communities, as well as the future of our planet. NEB remains a privately held company with global reach, supported by our headquarters in Ipswich, MA, USA, subsidiary offices in 10 countries, and over 60 distribution partners around the world. For more information about New England Biolabs, visit www.neb.com.
NEW ENGLAND BIOLABS® and NEB® are registered trademarks of New England Biolabs, Inc.
SOURCE New England Biolabs, Inc.
Leveraging NVIDIA's Latest GPU Architecture to Accelerate Innovations in Ultra-Low-Dose Imaging and Enhanced Lesion Visualization…
NEW YORK, March 18, 2025 /PRNewswire/ -- DarwinHealth is proud to have been named to Fast…
PARIS and SAN FRANCISCO, March 18, 2025 /PRNewswire/ -- Moon Surgical, a French-American pioneer in surgical…
TAMPA, Fla., March 18, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a…
Ansys and NVIDIA unveil vision for the future of cardiovascular research by democratizing simulation /…
BOGOTA, Colombia, March 18, 2025 /PRNewswire/ -- More than 500 executives, doctors, and healthcare personnel…